NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/23/2024
Back to search
Official data from USPTO
EYEFILL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
03/23/2024
Trademark type
Word
Nice classes
5
Filing date
05/12/2011
Registration date
05/01/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/07/2018
Last transaction
12/07/2018
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
IE
Examiner
HUGHITT, ELIZABETH
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Bausch + Lomb Ireland Limited
BAUSCH HEALTH IRELAND LIMITED
Valeant sp. z o. o. sp. j
C. M. (pessoa física)
Representatives
Robert Gorman Valeant Pharmaceuticals
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productsviscoelastic solutions for intraocular use
Publications
History of USPTO decisions and trademark events.
45 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/10/2023
CHLD
CHANGE OF OWNER RECEIVED FROM IB
01/07/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/27/2021
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
11/29/2019
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/29/2019
INPC
INVALIDATION PROCESSED
08/28/2019
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/07/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/11/2019
C71T
CANCELLED SECTION 71
12/07/2018
RNWL
INTERNATIONAL REGISTRATION RENEWED
11/30/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/19/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/19/2017
CHLD
CHANGE OF OWNER RECEIVED FROM IB
07/06/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/02/2017
CHLD
CHANGE OF OWNER RECEIVED FROM IB
02/12/2015
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/06/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/10/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/11/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/24/2013
FIMP
FINAL DISPOSITION PROCESSED
01/24/2013
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/08/2012
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/01/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
05/01/2012
PUBO
PUBLISHED FOR OPPOSITION
02/14/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/25/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/25/2012
NPUB
NOTICE OF PUBLICATION
01/25/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/12/2012
ALIE
ASSIGNED TO LIE
01/12/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/22/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/22/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/22/2011
RFNT
REFUSAL PROCESSED BY IB
11/12/2011
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/09/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/09/2011
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/26/2011
RFRR
REFUSAL PROCESSED BY MPU
10/26/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/26/2011
CNRT
NON-FINAL ACTION WRITTEN
10/25/2011
MAFR
APPLICATION FILING RECEIPT MAILED
10/25/2011
DOCK
ASSIGNED TO EXAMINER
10/19/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/19/2011
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
07/09/2011
Continuous trademark protection
Get notified about every new filing that threatens EYEFILL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.